Lilly appoints head of business development
January 8, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing darren carroll, lilly
Eli Lilly has promoted Darren Carroll to senior vice president of its corporate business development unit. Carroll has fulfilled the …
Exclusive: Novartis drug struck off cancer drugs fund
January 8, 2015Sales and Marketing Afinitor, Jevtana, NHS, NHS England, NICE, Novartis, Sanofi, everolimus
Novartis’ Afinitor (everolimus) will be removed from the Cancer Drugs Fund list when NHS England announces which drugs it can …
Gilead acquires Phenex liver disease drugs
January 7, 2015Research and Development, Sales and Marketing Farnesoid X Receptor, Gilead, liver, nafld, nash, phenex
Gilead Sciences has acquired Phenex Pharmaceuticals’ development programme for the treatment of serious liver diseases. The US biopharma firm will …
Amgen and Novartis start cancer immunotherapy push
January 7, 2015Research and Development, Sales and Marketing Amgen, Caribou Biosciences, Intellia Therapeutics, Novartis, kite pharma
Amgen and Novartis have launched new licensing agreements with biotech companies that they hope will lead to the development of …
Liberation Unlimited promotes Danielle Guildford-Sharp
January 7, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Creston, Danielle Guildford-Sharp, health unlimited, liberation unlimited
UK marketing and communications agency Liberation Unlimited has promoted Danielle Guildford-Sharp to the role of account manager. Since joining Liberation …
Director General of EFPIA: “Pan-European HTA necessary”
January 6, 2015London, January 5 2015: Richard Bergström, Director General, EFPIA argued passionately in favour of the homogenisation of European HTA bodies …
Vectura and J&J shake on asthma/COPD deal
January 6, 2015Research and Development, Sales and Marketing COPD, J&J, JJ, Janssen, asthma, johnson, rezolsta, tybost, vectura
British firm Vectura has entered an agreement with Johnson & Johnson’s pharma unit Janssen to develop therapies for asthma and …
Pfizer buys vaccine developer Redvax
January 6, 2015Research and Development, Sales and Marketing Pfizer, Vaccine, cmv, herpes, redbiotec, redvax, virus
Adding to its latest string of deals Pfizer has acquired vaccine developer Redvax – the pre-clinical arm of Swiss company …
BMS launches new fibrosis research collaboration
January 6, 2015Research and Development, Sales and Marketing BMS, BMS-986020, calibr, california, fibrosis, fibrotic
Bristol-Myers Squibb is entering into an agreement with the California Institute for Biomedical Research to develop new treatments for fibrotic …
Valeant recalls drug used on hospitalised infants
January 6, 2015Manufacturing and Production, Sales and Marketing Actavis, Allergan, FDA, Valeant, manufacturing, recall, ribavirin, virazole
North American drug firm Valeant Pharmaceuticals has issued a voluntary nationwide recall of Virazole due to microbial contamination. Virazole (ribavirin …
UK nurse with Ebola in ‘critical condition’
January 6, 2015Research and Development, Sales and Marketing Africa, Ebola, GSK, Mapp, WHO, cafferky, johnson, zmapp
A British nurse that was diagnosed with Ebola last week is said to be in a critical condition at the …
MRC head joins CPRD as director
January 6, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing MHRA, MRC, cprd, janet valentine
The Medicines and Healthcare products Regulatory Agency (MHRA) has announced an appointment of a new director for The Clinical Practice …
Next-generation Cempra antibiotic meets endpoints
January 5, 2015Research and Development, Sales and Marketing Antibiotics, FDA, cempra, moxifloxacin, solitaire-oral
Cempra Pharmaceuticals has become the first company to publish results from a Phase III study completed under FDA regulations governing …
Pharma industry set for bumper 2015
January 5, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2015, FDA, bumper, harvoni, opdivo, pharma, sovaldi
Industry analysts predict 2015 will be another year of growth for the pharma, after approvals of new drugs soared to …
Medical publishing: can we rely on it?
January 5, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Les Rose, csr, journals, medical publishing, peer, publishing, transparency
The explosive proliferation of journals suggests that medical publishing is an attractive business. But it’s not without its critics, as …
New CFO for Echo Therapeutics
January 5, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing alan schoenbart, echo therapeutics
US medical device firm Echo Therapeutics has appointed Alan Schoenbart as its chief financial officer.Schoenbart who has more than 30 …
Novo Nordisk obesity drug gets FDA nod
December 24, 2014Sales and Marketing FDA, Novo Nordisk, Victoza, diabetes, liraglutide, saxenda
The US Food and Drug Administration has shown Novo Nordisk’s obesity drug Saxenda the green light to aid chronic weight …
NHS plans bashed over cancer and heart disease
December 24, 2014Research and Development, Sales and Marketing Cancer, England, NHS, Simon Stevens, funding, heart
Hundreds of healthcare experts have signed an open letter to NHS chief executive Simon Stevens calling for him to scrap …
Actavis hires senior head from PwC
December 24, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actavis, Jonathon Kellerman, pwC
Jonathon Kellerman has joined Ireland-based speciality pharma firm Actavis as its executive vice president and global chief compliance officer. Reporting …
NICE rejects Takeda Crohn’s disease drug
December 23, 2014Sales and Marketing Crohn’s disease, Entyvio, NHS, NICE, Takeda, crohn's disease, vedolizumab
Takeda has seen its treatment for people with Crohn’s disease Entyvio rejected by NICE in an initial appraisal. The healthcare …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
